BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23125025)

  • 1. The effect of triple therapy versus etanercept plus methotrexate in rheumatoid arthritis: comment on the article by Moreland et al.
    Graudal N; Jürgens G
    Arthritis Rheum; 2013 Feb; 65(2):539. PubMed ID: 23125025
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply: The effect of triple therapy versus etanercept plus methotrexate in rheumatoid arthritis: comment on the article by Moreland et al.
    Moreland LW
    Arthritis Rheum; 2013 Feb; 65(2):539-40. PubMed ID: 23124989
    [No Abstract]   [Full Text] [Related]  

  • 3. Etanercept and methotrexate in rheumatoid arthritis.
    Malgarini RB; Pimpinella G
    Lancet; 2004 May; 363(9422):1733; author reply 1733. PubMed ID: 15158641
    [No Abstract]   [Full Text] [Related]  

  • 4. Etanercept tapering in rheumatoid arthritis.
    Graudal N; Jürgens G
    N Engl J Med; 2015 Jan; 372(5):489. PubMed ID: 25629752
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of rheumatoid arthritis with etanercept].
    Lamprecht P; Nitschmann S
    Internist (Berl); 2009 May; 50(5):633-4. PubMed ID: 19350212
    [No Abstract]   [Full Text] [Related]  

  • 6. Etanercept and methotrexate in rheumatoid arthritis.
    Poteliakhoff A
    Lancet; 2004 May; 363(9422):1734. PubMed ID: 15158644
    [No Abstract]   [Full Text] [Related]  

  • 7. Etanercept tapering in rheumatoid arthritis.
    Emery P; Hammoudeh M; Combe B
    N Engl J Med; 2015 Jan; 372(5):489-90. PubMed ID: 25629751
    [No Abstract]   [Full Text] [Related]  

  • 8. COMET's path, and the new biologicals in rheumatoid arthritis.
    Kremer JM
    Lancet; 2008 Aug; 372(9636):347-8. PubMed ID: 18635257
    [No Abstract]   [Full Text] [Related]  

  • 9. Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.
    Smolen JS; Nash P; Durez P; Hall S; Ilivanova E; Irazoque-Palazuelos F; Miranda P; Park MC; Pavelka K; Pedersen R; Szumski A; Hammond C; Koenig AS; Vlahos B
    Lancet; 2013 Mar; 381(9870):918-29. PubMed ID: 23332236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosage and mode of administration of methotrexate in clinical trials: comment on the article by Genovese et al.
    Seitz M; Villiger PM
    Arthritis Rheum; 2003 Mar; 48(3):863. PubMed ID: 12632454
    [No Abstract]   [Full Text] [Related]  

  • 11. COMET results are not stellar.
    James M; Cleland L
    Lancet; 2008 Nov; 372(9652):1807-8; author reply 1808. PubMed ID: 19027480
    [No Abstract]   [Full Text] [Related]  

  • 12. Two RA drugs better than one.
    Health News; 2004 May; 10(5):10. PubMed ID: 15132111
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy.
    van der Heijde D; Burmester G; Melo-Gomes J; Codreanu C; Martin Mola E; Pedersen R; Robertson D; Chang D; Koenig A; Freundlich B;
    Ann Rheum Dis; 2009 Jul; 68(7):1113-8. PubMed ID: 18718986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations.
    Kremer JM; Weinblatt ME; Bankhurst AD; Bulpitt KJ; Fleischmann RM; Jackson CG; Atkins KM; Feng A; Burge DJ
    Arthritis Rheum; 2003 Jun; 48(6):1493-9. PubMed ID: 12794815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Missing the obvious.
    Nuenninghoff DM
    J Rheumatol; 2009 Aug; 36(8):1833; author reply 1833. PubMed ID: 19671823
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Symmons DP; Watson KD; Silman AJ;
    Arthritis Rheum; 2006 Jun; 54(6):1786-94. PubMed ID: 16736520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methotrexate for therapy of rheumatoid arthritis].
    Suzuki Y; Wakabayashi T; Jackson K
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():498-502. PubMed ID: 15799406
    [No Abstract]   [Full Text] [Related]  

  • 18. Trial of etanercept and methotrexate with radiographic and patient outcomes two-year clinical and radiographic results: Comment on the article by van der Heijde et al.
    Yazici Y; Yazici H
    Arthritis Rheum; 2006 Sep; 54(9):3061-2. PubMed ID: 16948140
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial.
    van der Heijde D; Klareskog L; Rodriguez-Valverde V; Codreanu C; Bolosiu H; Melo-Gomes J; Tornero-Molina J; Wajdula J; Pedersen R; Fatenejad S;
    Arthritis Rheum; 2006 Apr; 54(4):1063-74. PubMed ID: 16572441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between adalimumab, etanercept, and infliximab in rheumatoid arthritis: comment on the article by Hetland et al.
    Francis S; Block MJ
    Arthritis Rheum; 2010 Sep; 62(9):2826; author reply 2826-8. PubMed ID: 20556822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.